Pfizer and Moderna vaccines prove 92 percent effective with just 1st dose


Just one dose of the Moderna and Pfizer two-shot coronavirus vaccines is seemingly nearly as good two.
In a study published Thursday in the New England Journal of Medicine, a pair of Canadian-based researchers suggested an amendment to the determined efficacy of the Pfizer vaccines after just one shot. While Pfizer and BioNTech reported their vaccine was just 52.4 percent effective at preventing infection after the first dose, the researchers noted that this data includes results from within the first two weeks after inoculation, "when immunity would have still been mounting." After two weeks, that efficacy mounted to 92.6 percent, matching the first-dose efficacy of 92.1 percent reported from the Moderna vaccine as well. After two doses, the Pfizer vaccine is 95 percent effective, and Moderna's is 94 percent.
The Canadian-based researchers' interpretations of the Pfizer results led them to suggest in the letter that vaccine distributors delay giving people the second dose. This would let distributors get first doses to more at-risk people instead of leaving them "completely unprotected" — something the researchers called "a matter of national security that, if ignored, will certainly result in thousands of COVID-19–related hospitalizations and deaths this winter in the United States."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Another study from January led Pfizer and BioNTech to say Wednesday that they are unsure if the vaccine will be effective at protecting against the B.1.351 variant first found in South Africa. The study published in the New England Journal of Medicine found the vaccine was still capable of neutralizing the virus within the B.1.351 strain, and that trials haven't shown the variant reduces the vaccine's protection in people. Still, the companies may end up creating a booster shot to ensure the vaccine remains effective against the highly transmissible strain.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Is this the end for India's Maoist insurgency?
Under The Radar Narendra Modi clamps down on Naxalite jungle rebels in move some see as attempt to seize mineral wealth
-
Discrimination: Expanding the definition
Feature The Supreme Court ruled in favor of a straight woman who sued her gay boss for discrimination
-
Crime: Why murder rates are plummeting
Feature Despite public fears, murder rates have dropped nationwide for the third year in a row
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments